Japanese company profile · 3353

Medical Ikkou Group Co.,Ltd.

English company name recorded in Japan's EDINET filer data.

Original Japanese company name: 株式会社メディカル一光グループ

Name follows the English name recorded in EDINET filer data. English company name source

FY2025 · fiscal year ended February 2026Latest filing date: 2026-05-19

What does this company do?

What does this company do?

In its FY2025 public filing, Medical Ikkou Group Co.,Ltd. reports Pharmacy, Healthcare, Pharmaceutical wholesale, Real Estate. The page shows business-level revenue and profit where the source disclosures support comparison.

Medical Ikkou Group Co.,Ltd.'s largest reported business by revenue in FY2025 was Pharmacy.

The business with the highest reported segment profit in FY2025 was Pharmacy.

FY2025 · fiscal year ended February 2026 · View original filing ↗ The source document may be in Japanese.

Reported company-wide figures

Company revenue
¥54.98B ↗
FY2025 · fiscal year ended February 2026
Operating profit
¥1.79B ↗
FY2025 · fiscal year ended February 2026
Comparable margin
3.3% ↗
FY2025 · fiscal year ended February 2026

JGAAP · Consolidated company-wide

Company profile

Company profile

Identity

Securities code
3353
EDINET code
E03443
Corporate number
2190001001175
Listing status
Listed
Industry (EDINET filer classification)
Retail trade

Location and fiscal year

Headquarters
三重県津市 · As filed in Japanese
Latest fiscal year
FY2025
Accounting standard
JGAAP
P16 data snapshot
2026-11-07

Company size

Employees (consolidated)
1,608 people (FY2025)
Employees (non-consolidated)
30 people (FY2025)
Capital stock
JPY 917.0 million (FY2025)

Official information

Public information is organized and presented by P16. EDINET filer list (2026-11-07) Opens in a new tab · EDINET PDL 1.0 terms Opens in a new tab

Business structure

How does it make money?

Revenue leader and profit leader

Pharmacy

FY2025 · fiscal year ended February 2026 · Business Sales Operating profit
BusinessSalesShare of company salesOperating profitMargin
Pharmacy¥26.29B ↗47.8%47.8%Sales to external customers: ¥26.29B ↗¥1.37B ↗5.2%
Pharmaceutical wholesale¥20.64B ↗35.4%35.4%Sales to external customers: ¥19.45B ↗¥287.22M ↗1.4%
Healthcare¥8.99B ↗16.4%16.4%Sales to external customers: ¥8.99B ↗¥111.53M ↗1.2%
Real Estate¥265.28M ↗0.5%0.5%Sales to external customers: ¥254.34M ↗¥144.61M ↗54.5%

All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended February 2026. Revenue and profit are shown only where the filing and data support a comparison. “—” means a comparable amount was not disclosed. We compare sales to outside customers for each business and the company as a whole, using the same filing, fiscal year and scope. Reported business sales may include sales between businesses. We leave the share blank when the figures cannot be matched.

Company revenue

Company-wide trend

Company revenue

JGAAP · Consolidated
  1. FY202161.1¥33.6B
  2. FY202261.7¥33.9B
  3. FY202372.6¥39.9B
  4. FY202488.0¥48.39B
  5. FY2025100.0¥54.98B

Company operating profit

JGAAP · Consolidated
  1. FY202171.4¥1.28B
  2. FY202252.3¥935.17M
  3. FY202387.2¥1.56B
  4. FY202494.6¥1.69B
  5. FY2025100.0¥1.79B

Only reported years are shown. Missing years are left blank; accounting standards and scopes are kept in separate series.

Reported Sales by business over time

Reported Sales by business over time

Fiscal yearFY2021FY2022FY2023FY2024FY2025
Pharmacy¥22.73B¥23.09B¥23.54B¥24.71B¥26.29B
Healthcare¥7.81B¥7.67B¥7.75B¥8.12B¥8.99B
Pharmaceutical wholesale¥3.89B¥3.94B¥9.31B¥16.2B¥20.64B
Real Estate¥233.2M¥189.05M¥185.64M¥208.4M¥265.28M

All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.

What is growing?

What is growing?

Business revenue growth

This describes a reported period; it is not a forecast.

What has changed?

What has changed?

A five-year business-mix comparison is not shown because the available filings do not provide five comparable years on the same basis.

Source

Company profile

These scores summarize company characteristics using public filings. Comparison groups vary by measure. Higher is not always better.

  • Growth75
    Peer-position scoreFY2025
  • Profitability49
    Peer-position scoreFY2025
  • Business concentration15
    Peer-position scoreFY2025
  • Business change96
    Peer-position scoreFY2021→FY2025
  • Cash generation24
    Peer-position scoreFY2025
  • Growth persistence79
    Peer-position scoreFY2021→FY2022, FY2022→FY2023, FY2023→FY2024, FY2024→FY2025

Next

Ask about this company

Source

Public filing

FY2025 · fiscal year ended February 2026

The source document may be in Japanese.

Filing ID: S100Y4Y9

View original filing ↗

根拠となる資料